{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:22:03Z","timestamp":1767828123597,"version":"3.49.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T00:00:00Z","timestamp":1431388800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T00:00:00Z","timestamp":1431388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1111\/bjd.13823","type":"journal-article","created":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T13:40:59Z","timestamp":1427895659000},"page":"858-859","source":"Crossref","is-referenced-by-count":36,"title":["Paradoxical worsening of pemphigus vulgaris following rituximab therapy"],"prefix":"10.1093","volume":"173","author":[{"given":"R.J.","family":"Feldman","sequence":"first","affiliation":[{"name":"Department of Dermatology; Emory University; 1525 Clifton Rd 1st floor Atlanta GA 30322 U.S.A"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,5,12]]},"reference":[{"key":"10.1111\/bjd.13823-BIB0001|bjd13823-cit-0001","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1586\/eci.11.22","article-title":"Relevance of rituximab therapy in pemphigus vulgaris: analysis of current data and the immunologic basis for its observed responses","volume":"7","author":"Feldman","year":"2011","journal-title":"Exp Rev Clin Immunol"},{"key":"10.1111\/bjd.13823-BIB0002|bjd13823-cit-0002","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"A single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.13823-BIB0003|bjd13823-cit-0003","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jamadermatol.2013.6739","article-title":"Durable remission of pemphigus with a fixed-dose rituximab protocol","volume":"150","author":"Heeelan","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1111\/bjd.13823-BIB0004|bjd13823-cit-0004","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jamadermatol.2014.2421","article-title":"First-line treatment of pemphigus vulgaris with a combination of rituximab and high-potency topical corticosteroids","volume":"151","author":"Ingen-Housz-Oro","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1111\/bjd.13823-BIB0005|bjd13823-cit-0005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1182\/blood-2010-01-266668","article-title":"Am\u201cB\u201dvalent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis","volume":"116","author":"Thaunat","year":"2010","journal-title":"Blood"},{"key":"10.1111\/bjd.13823-BIB0006|bjd13823-cit-0006","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1002\/art.22811","article-title":"Development of psoriasis after B cell depletion with rituximab","volume":"56","author":"Dass","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1111\/bjd.13823-BIB0007|bjd13823-cit-0007","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1056\/NEJMc0808481","article-title":"B-cell-depleting induction therapy and acute cellular rejection","volume":"360","author":"Clatworthy","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.13823-BIB0008|bjd13823-cit-0008","first-page":"3420","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1111\/bjd.13823-BIB0009|bjd13823-cit-0009","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/annonc\/mdh403","article-title":"Paradoxical increases in serum IgM and viscosity levels following rituximab in Waldenstrom's macroglobulinemia","volume":"15","author":"Treon","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1111\/bjd.13823-BIB0010|bjd13823-cit-0010","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.exphem.2013.04.006","article-title":"Rituximab activates Syk and AKT in CD20-positive B cell lymphoma cells dependent on cell membrane cholesterol levels","volume":"41","author":"Nozaki","year":"2013","journal-title":"Exp Hematol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.13823","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.13823","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.13823\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:15:01Z","timestamp":1676384101000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/173\/3\/858\/6627440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,12]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.13823","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5,12]]}}}